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Abstract
Gene regulatory networks give important insights into the mechanisms underlying physiology and pathophysiology. The
derivation of gene regulatory networks from high-throughput expression data via machine learning strategies is
problematic as the reliability of these models is often compromised by limited and highly variable samples, heterogeneity in
transcript isoforms, noise, and other artifacts. Here, we develop a novel algorithm, dubbed Dandelion, in which we construct
and train intraspecies Bayesian networks that are translated and assessed on independent test sets from other species in a
reiterative procedure. The interspecies disease networks are subjected to multi-layers of analysis and evaluation, leading to
the identification of the most consistent relationships within the network structure. In this study, we demonstrate the
performance of our algorithms on datasets from animal models of oculopharyngeal muscular dystrophy (OPMD) and
patient materials. We show that the interspecies network of genes coding for the proteasome provide highly accurate
predictions on gene expression levels and disease phenotype. Moreover, the cross-species translation increases the stability
and robustness of these networks. Unlike existing modeling approaches, our algorithms do not require assumptions on
notoriously difficult one-to-one mapping of protein orthologues or alternative transcripts and can deal with missing data.
We show that the identified key components of the OPMD disease network can be confirmed in an unseen and
independent disease model. This study presents a state-of-the-art strategy in constructing interspecies disease networks
that provide crucial information on regulatory relationships among genes, leading to better understanding of the disease
molecular mechanisms.
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Introduction
The degree to which gene products appear in the cell and exert
their function is regulated through interactions with other genes.
This interconnectivity implies that the identification of gene
regulatory networks is vital for understanding the phenotypic
impacts of gene defects and the associated complications [1–4].
The dawn of high-throughput technologies such as genome-wide
sequencing and microarray experiments has increased our
understanding of molecular behavior at the transcriptional level.
Although these large-scale datasets provide crucial information
about both the presence and relative abundance of RNA
transcripts, they also introduce an important challenge in
providing a comprehensive view of molecular mechanisms and
regulatory relationships among genes with different underlying
phenotypic conditions.
The presence of this obstacle calls for developing robust
machine learning models that can be used for generating gene
networks in which their transcriptional changes can affect
phenotypic outcome. However, building a network that involves
thousands of genes and millions of interactions is extremely
problematic and requires a great quantity of experimental data for
the valid interpretation of biological causes for a given phenotype.
Furthermore, the validity of gene regulatory networks is often
affected by limited and highly variable samples, heterogeneity in
transcript isoforms, noise and other artifacts [5–8]. Therefore, a
probabilistic approach is needed to identify and predict intercon-
nected transcriptional behaviors that give rise to disease outcome
[9] and to, ultimately, offer potential targets for therapeutic
intervention and drug development. Among the possible statistical
models, Bayesian networks have been an important concept for
modeling uncertain systems [10–13]. Bayesian networks can
represent complex stochastic relationships between genes and
are capable of integrating different types of data (i.e. phenotype
and genotype categorical information as well as gene expression
data). In addition, the probabilistic nature of such networks can
accommodate noise and missing data by weighting each
information source according to its reliability. In contrast to many
statistical models, the transparent nature of Bayesian networks (in
terms of the graphical structure and local probability distributions)
leads to better interpretation and understanding of the underlying
biological regulation of the disease.
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The high dimensionality of the genome wide expression
profiling datasets and the limited number of available samples
complicates the derivation of robust network structures. Methods
such as the use of prior knowledge about biological interactions
[13–15] have been shown to successfully reduce the search space
and to make networks more robust. This method works for well-
studied diseases or biological systems, but is not likely to identify
novel regulatory interactions underlying the molecular mecha-
nisms of rare or complex disorders. In addition, this bias can
falsely expose the network to sample differences in the absence of a
disease-related biological cause. In this study, we hypothesize that
biologically relevant relationships between genes are often
conserved across species. Thus, the robustness and stability of a
gene network should increase when modeling regulatory networks
using related datasets from different species. Moreover, we
hypothesize that the relationships identified in an interspecies
gene network should be biologically more meaningful. On the
other hand, cross-species translation of networks is far from trivial
given our limited knowledge of true protein orthologues and
transcript variants coding for proteins with similar functions in
different species. Therefore, we explore the performance of a novel
algorithm that combines our previously published model for
learning regulatory interactions from multiple datasets of increas-
ing complexity [16] with an interspecies translation and validation
regime, named Dandelion algorithm. We show that the supplemen-
tation of this algorithm with a modeling-driven selection of
transcripts coding for orthologous proteins (exhaustive Dandelion
algorithm) significantly improves the robustness and stability of the
interspecies network, when compared to a standard approach in
which expression levels of different transcripts for the same gene
are summarized (naı¨ve Dandelion algorithm). We also show that
the potential regulatory relationships that play a role in interspecies
disease networks can be reproduced and validated in an unseen and
independent model system.
In this study, three publicly available microarray datasets from
Drosophila [17], mouse [18], and human [19] that are all concerned
with oculopharyngeal muscular dystrophy (OPMD) have been
chosen to gain insight into the key regulators of the disease. These
datasets are described in Table 1. OPMD is a late-onset
progressive muscular disorder for which the underlying molecular
mechanisms are largely unknown. This autosomal dominant
muscular disorder has an estimated prevalence of 1 in 100,000
worldwide [20]. OPMD is caused by the expansion mutation of a
homopolymeric alanine stretch at the N-terminus of the Poly(A)
Binding Protein Nuclear 1 (PABPN1) by 2–7 additional Ala
residues [21]. Although PABPN1 is ubiquitously expressed, the
clinical and pathological features of OPMD are restricted to a
subset of skeletal muscles, causing progressive ptosis, dysphagia, and
limb muscle weakness. Drosophila and mouse models with muscle-
specific overexpression of expanded PABPN1 recapitulate pro-
gressive muscle weakness in OPMD [22,23]. However, the
potential artifact, heterogeneity in transcript isoforms, and the
presence of overexpression side-effects in OPMD animal models
and limited patient materials complicate the identification of key
regulators of OPMD. With the analysis of these datasets, we
demonstrate that modeling of interspecies disease networks increases
the robustness of the networks and aids in the identification of key
regulators of the disease.
Methods
Model of Interspecies Networks Using Dandelion
Algorithm
To construct interspecies networks that can accurately predict the
disease phenotype and provide a comprehensive view of molecular
relationships that underlie the disease-associated biological
processes, we developed a novel Dandelion algorithm with multi-
layers of analysis and evaluation criteria. A schematic presentation
of this approach can be found in Figure 1. In addition, the
definition of nomenclatures (italicized terms) used in this study is
provided in the Table S1 in Text S1.
The procedure starts with the identification of the disease-
associated modules by assessing the association of transcriptional
profiles with the disease state. In this study, gene modules are
defined according to current KEGG (Kyoto Encyclopedia of
Genes and Genomes) annotation of molecular pathways to ensure
functional relationships among genes within the same cluster.
After identification of the disease module, the set of genes in the
disease module is supplemented with a set of randomly selected
genes for the purpose of network performance estimation and
evaluation. The Dandelion algorithm integrates three recurring
phases of training and independent testing with the use of
multiple datasets derived from the different biological systems.
This involves a reiterative selection of one species as an organism
in which intraspecies gene regulatory networks are constructed.
Cross-validation is used for learning and optimization of the
intraspecies network structure. Some partitions were purely used
for testing the intraspecies network to ensure, in all experiments,
that the test data is previously unseen. Datasets from the other
species are used for interspecies translation, independent testing and
validation of the constructed disease networks. The construction
of intraspecies Bayesian networks is governed by our previously
published optimization procedure [16]. To ensure that these
interspecies networks are derived from a disease-related biological
cause, the specificity and sensitivity of the networks for prediction of
the disease phenotype are assessed. Moreover, the robustness and
translatability at different confidence thresholds are evaluated. After
defining the interspecies disease domains, a subset of genes is selected
for unbiased examination of reproducibility and validity of
disease-related transcriptional changes in an unseen and
independent model system. The detailed outline of the proce-
dure, depicted in Figure 1, is provided in the following
subsections.
Author Summary
The identification of gene regulatory networks can provide
vital information on biological processes. Despite numer-
ous advancements in developing machine learning strat-
egies, the stochastic nature of such biological systems
complicates the construction of robust and reliable
network structures. In recent years, the use of cross-
species datasets enabled scientists to better understand
the molecular mechanisms that are associated with human
disorders. However, it also presents a challenge in dealing
with especially difficult mapping of protein orthologues,
alternative transcript splicing, noise, or other artifacts.
Here, we developed a novel algorithm for constructing
interspecies disease networks that provide accurate
predictive value over the disease phenotype and gene
expression. We show that the disease-association of
potential key regulators that play a role in interspecies
disease networks can be reproduced and validated in an
unseen and independent model system. This study
presents a novel strategy for constructing networks that
can be translated across species whilst providing a
comprehensive view of regulatory relationships associated
with the disease.
Disease-Related Interspecies Regulatory Networks
PLoS Computational Biology | www.ploscompbiol.org 2 November 2011 | Volume 7 | Issue 11 | e1002258
Disease modules. Disease modules have been identified
according to our previously published study [19] in which we
performed an integrated transcriptome analysis to identify the
most significant molecular pathways that are associated with the
OPMD across species.
Bayesian network structure learning. A Bayesian network
encodes the joint probability distribution of a set of random
variables. It consists of a directed acyclic graph (DAG) that
represents conditional independencies between variables, and
conditional distributions at each node in the graph. Bayesian
network classifiers are a special case of Bayesian networks where
one node represents some discrete class to be predicted. Here,
each node in the graph represents a gene transcript (or gene) and
the class node represents the disease states. In order to learn the
Bayesian network structure of a gene network, the algorithm
approximates the likely graphical model by searching the space of
possible networks via single-arc changes that improves some score.
We use a simulated annealing search in conjunction with the
Bayes Information Criterion (BIC) as a scoring metric [24].
Simulated annealing performs competitively with other
optimization methods as it aims to avoid local maxima [25].
There is a trade-off between simplicity of model with one that can
accurately identify the empirical distribution of gene expression
profiles and predict the disease phenotypic outcome. For this
reason the BIC is used as it is less prone to overfitting through the
use of a penalizing term for overly complex models.
The initial state of the structure is an empty DAG with no links.
In order to alter the network structures, three operations have
been used within the simulated annealing procedure. These
operators are adding, removing, or swapping links to generate a new
network which can be either accepted or rejected based on its
overall score and the current temperature. The outline of this
algorithm can be found in the Protocol S1 in Text S1.
In this study, the initial temperature (t0) has been set to 10 and it
terminates at 0.001 (tn), according to our previously published
optimization procedure [16]. The number of iterations (maxfc) has
been set to 1000 in respect to the number of nodes available in the
network. The training dataset is described as D. For the training
phase, the mode variable is set to ‘‘train’’ and the variable
networkMap is set to empty. During the interspecies translation and
testing, the variable mode is set to ‘‘test’’ and the variable
networkMap holds information on the regulatory relationships that
are present in the network map constructed on training organism.
Construction of interspecies networks. The Dandelion
algorithm takes multiple datasets from different species as input. In
this study, we launch two classes of Dandelion algorithm. Firstly, the
naı¨ve Dandelion algorithm, where the expression patterns of gene
transcripts are summarized by averaging the expression profiles of
gene probes, to provide one expression profile per gene. This enables
direct mapping of expression profiles of orthologous genes when
translating networks across species. This approach significantly
simplifies the process of constructing network structures. Secondly,
we developed the exhaustive Dandelion algorithm to overcome the
limitations caused by heterogeneity in transcript isoforms, differences
in annotation between organisms and technical factors (i.e. different
microarray platforms). In the exhaustive algorithm, transcripts that
are most likely to be coding for orthologous proteins are selected
automatically in the modeling phase.
The procedure involves reiterative selection of one species for
construction of the Bayesian network while other species are left
aside for independent testing and validation of learnt disease
networks. The highest-scoring intraspecies network structure is
learnt according to the algorithm described in the Protocol S1 in
Text S1. Before interspecies translation, in the exhaustive
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Dandelion algorithm, a detailed interaction map of a candidate
intraspecies disease network of gene transcripts needs to be
transformed to a network map of gene-gene relationships. This
step can be omitted in the naı¨ve Dandelion algorithm as the
constructed intraspecies networks are already at the gene level.
Using the cross-validation and network optimization procedure, the
algorithm searches through the relationships present in the network
map (constructed on the training set) to find the best fit for the
Figure 1. Schematic overview of the Dandelion algorithm for disease network analysis. The Dandelion algorithm involves three recurring
stages of training and independent testing regime with the use of multiple datasets derived from different species. In the first step, disease modules
are defined as the most consistently disease-associated molecular pathway across species. The disease module is supplemented by a set of randomly
selected genes to assess the performance of the algorithm and to check for overfitting. These datasets are standardized to mean 0 and standard
deviation of 1 across genes. The next step involves reiterative selection of one species as an organism in which the gene regulatory network is
constructed while others are left aside for independent testing and validation of learnt disease networks. For an intraspecies construction of disease
network, dataset is divided into k-folds, using cross-validation, and regulatory relationships between gene transcripts are learnt using Bayesian
network methodology enhanced by simulated annealing optimization of network BIC score. After applying confidence thresholds on relationship
between genes, the disease network can then be translated to the expected interspecies disease network which we call a network map. Using the
cross-validation and network optimization procedure the algorithm searches through the relationships found in the training dataset to find the best
fit for interspecies representation of the disease network. These networks are then integrated by removing all the links with low confidence score
across species.
doi:10.1371/journal.pcbi.1002258.g001
Disease-Related Interspecies Regulatory Networks
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interspecies representation of the disease network. These networks
are then integrated by removing all the links with a low confidence
score to construct the consensus interspecies disease networks. The
full algorithm details are outlined in the Protocol S2 in Text S1
where Speciestrain and trainfolds represent the training dataset and the
folding arrangements for the selected organism. Furthermore, the
series of Speciestest 1 … Speciestest M and testfolds 1 … testfolds M represent
the datasets and folding arrangements of organisms that are selected
for independent test and validation. The logical variable exhaustive
indicates the class of Dandelion algorithm (naı¨ve in case of false and
exhaustive in case of true) that needs to be performed.
In this study, the human dataset is divided into 4 folds due to the
limited number of patient samples. Mouse and Drosophila datasets
are divided into 6 folds. The average Sum of Squared Error (SSE) and
standard deviation (STD) are calculated for all nodes over these
folds by predicting the measured expression values of genes (or
gene transcripts) given the measurements taken from others. For
the class node, the state of the disease is predicted given the
expression profiles for genes (or gene transcripts) within the
network structure. The number of iterations was set to 1000 for
the training phase and was reduced to 500 during the interspecies
translation of disease networks. The code is implemented in
Matlab 2008b using the Bayes Net toolbox [26].
Network analysis and evaluation. The proposed approach
consists of three layers of analysis and evaluation. The constructed
interspecies disease networks are assessed for their predictive
accuracy towards the disease phenotype (class node) by
calculation of the level of sensitivity and specificity. Furthermore,
the Bayesian networks Sum of Squared Error (SSE) is calculated for
prediction of the expression of all genes (or gene transcripts).
Moreover, the level of robustness and translatability of the
generated networks are evaluated. The stability and robustness of
relationships between genes within the disease module are
compared to those of the random genes at different confidence
score thresholds. Confidence scores are the ratio of the number of
times a link is found in the interspecies disease networks to the
maximum number of times the link can possibly be found (based
upon the number of folds). For approximating the level of
translatability, the total number of links found during the training
phase is compared to the number of links that were successfully
translated to other species. Finally, the interspecies disease domains
are defined based on the Markov blanket principle for the extension
of the class node connectivity. In addition, unstable gene
interactions are removed through assessment of the level of
confidence in the relationships between genes. The interspecies
disease domains are used to select a subset of genes to further study
the reproducibility and validity of the observed relationships
towards their association with the disease phenotype in an unseen
and independent OPMD model system.
To assess the specificity of genes encoding for the proteasomal
proteins in accurately predicting the disease states, we generated
three additional gene sets. A set of 100 randomly selected genes, 87
genes within the ribosome pathway, and 70 randomly selected genes
with the constraint of none being deregulated (ND) constitute the
three genes sets that are used in a comparative analysis. The human
dataset is used for cross-validation whilst mouse and Drosophila
datasets were used for independent assessment of the constructed
networks. Networks are evaluated on their sensitivity, specificity, and
predictive accuracy towards the disease state (OPMD or control).
Microarray Datasets
The human, mouse, and Drosophila microarray datasets have
been previously published [17–19]. The human and mouse
datasets are publicly available at GEO repository under the
accession numbers GSE26605 and GSE26604, respectively. In all
datasets genome-wide expression profiles of skeletal muscles from
OPMD are compared to controls. In case there are multiple
probes for the same gene on the microarray platforms, these
probes usually measure the expression levels of different transcripts
from the same gene. The class node reflects the disease phenotype
(control or OPMD) of each sample. A detailed description of these
datasets can be found in Table 1.
Data Processing and Statistical Analysis
Microarray measurements were normalized using the quantile
method. In addition, these datasets were standardized to mean 0 and
standard deviation 1 across the genes. For the scope of this paper, the
human proteasome-encoding genes were annotated using illumina-
Humanv3BeadID package in R and the mouse and Drosophila
homologous were annotated using HomoloGene and Inparanoid
(http://ncbi.nlm.nih.gov/homologene and http://inparanoid.sbc.su.
se, respectively) online databases. Previously published data were used
to identify deregulated genes per species [19]. For cross-validation
[27,28] human data were divided into 4 folds (given the limited
number of OPMD samples), while the other datasets were divided into
6 folds (Table 1). Human, mouse, and Drosophila datasets hold 108,
96, and 78 transcripts, respectively, which encode for 74, 56, and 53
genes (including genes encoding for the proteasome and a set of 30
randomly selected genes). The differences are due to limitations of
mapping homologous genes or unavailability of expression data for
certain genes in a particular species. The gene lists are provided in the
Table S2 in Text S1.
Cell Model
IM2 cells stably transfected with normal (WTA) or expanded
PABPN1 (D7E) and were compared to assess the predictive value of
the interspecies modeling approach on an unseen OPMD disease
model [29]. Exogenous PABPN1 expression is under control of the
desmin promoter. IM2 cells were proliferated in DMEM supple-
mented with 20% fetal calf serum, 0.5% chicken embryo extract,
5 U/ml interferon gamma, at 33C and 10% CO2. Myotube fusion
was induced by culturing in DMEM supplemented with 5% horse
serum at 37C and 5% CO2 for four days, after which RNA was
extracted from three independent cultures.
Quantitative RT-PCR Analysis
Total RNA was extracted using the TRIZOL reagent
(Invitrogen) according to manufacturer’s instruction. First strand
cDNA was synthesized with random hexamer oligonucleotides
and MMLV reverse transcriptase (First Strand Kit; Fermentas,
according to manufacturer’s instruction). 3.6 ng cDNA was used
per quantitative PCR reaction. qPCR was performed with SYBR
green mix buffer (BioRad) and 7.5 pmole (per reaction) of forward
and reverse primers in a 15 mL reaction volume. PCR conditions
were as follows: 4 min at 95uC followed by 40 cycles of 10 sec at
95uC and 60 sec at 60uC. The program was ended with 1 min at
60uC. For each primer set, the specificity of the PCR products was
determined by melting curve analysis. Expression levels were
calculated according to the DDCT method normalized to mHrpt,
Desmin, and IM2 parental cells. The statistical significance was
determined with the student’s t-test. The list of primers used in this
study is provided in the Table S3 in Text S1.
Results
Identification of Disease Module
Previously we identified that the deregulation of the ubiquitin-
proteasome system (UPS) is the predominant molecular pathway
Disease-Related Interspecies Regulatory Networks
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affected in OPMD animal models and patients [19]. The UPS, a
cellular regulator of homeostasis, is highly dynamic machinery that
involves protein ubiquitination and degradation steps. From the
six UPS components, we found that only E3-ligases, deubiquiti-
nating enzymes, and proteasome components are consistently and
prominently deregulated in OPMD across species [19]. The
proteasome is composed of core and regulatory subunits. We
observed a substantial deregulation of proteasome and cytokine-
induced proteasome (also known as immunoproteasome) encoding
genes across species (Figure 2). To obtain more insight in the key
components in the proteasome machinery that are aberrantly
expressed in OPMD across species, we generated gene regulatory
networks. Unique to the current approach, the networks were
learnt on one species and evaluated on datasets from other species.
This was done to only retain those links between genes that can be
found across multiple species and that are more likely to be
directly connected to the disease phenotype than links that are
only found in a single species. For the interspecies translation we
used two version of our newly developed Dandelion algorithm.
The naı¨ve variant is a straw man approach, where expression
values for different transcripts of the same gene are first
summarized. This approach was then further refined in the
exhaustive Dandelion algorithm, where the model chooses the
transcript that is most predictive for the expression value of a
transcript in another species.
Naı¨ve Construction of Disease Network
The process of constructing disease networks using naı¨ve
Dandelion algorithm initially starts by averaging the expression
profiles of different gene transcripts in the human datasets. The
summarized gene expression values were then used for the
learning of intraspecies gene networks which consequently were
translated to the other species. The interspecies networks were
assessed for their predictive accuracy, sensitivity and specificity
(Figure 3). The constructed interspecies networks predict the
disease status (control vs. OPMD) of the unseen Drosophila and
mouse samples with a moderate accuracy of 71% and 72%,
respectively (Figure 3A). However, a large number of networks
perform worse than random expectations, as evident from the
ROC space (Figure 3B). This result indicates an overall low
Figure 2. OPMD-deregulation across different subunits of the proteasome in different species. There are widespread differences in gene
expression (depicted in dark colors) between OPMD and control in the different functional subunits of proteasome and immunoproteasome in
human (A), mouse (B) and Drosophila (C). The Significance of the association between the disease outcome and expression profiles of genes
encoding for proteasome and immunoproteasome were previously calculated [19] using the global test [46].
doi:10.1371/journal.pcbi.1002258.g002
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level of sensitivity and specificity in predicting the disease
phenotype. Moreover, the networks are weak and unstable as
they exhibit a very low level of translatability (Figure 3C). The
low level of robustness, stability and translatability is also evident
from the low percentage (8.7%) of relationships with the
confidence score of $0.1 in the intraspecies networks
(Figure 3D). Similarly, after applying the confidence threshold
of 0.1, the interspecies disease domain structure collapses as only
two links survive this constraint (Figure 3E). The level of
confidence in relationships within the interspecies disease domain
is estimated to be between 0.25 and 0.75 for both links and RPN9
is the only gene found differentially expressed in the Drosophila
dataset. This indicates that averaging the expression patterns for
different gene transcripts reduces the information content of the
network considerably and should be avoided for accurate
prediction of the disease phenotype and generating biologically
relevant regulatory networks.
Exhaustive Construction of Disease Network
We used the exhaustive Dandelion algorithm to overcome these
limitations and provide a detailed interaction map of molecular
pathology that extends our knowledge of disease mechanism
across species. In contrast to the naı¨ve variant, the exhaustive
Dandelion algorithm searches the space of possible relationships at
the level of gene transcripts to find the best scoring interspecies
regulatory network. It can accommodate missing data and possible
dissimilarities by identifying the best fit for a given relationship
across species.
Bayesian networks which are generated using the exhaustive
Dandelion algorithm can accurately predict the disease status from
the expression levels of genes coding for proteasomal components
(Figure 4A). We observe over 91% sensitivity and 80% specificity
in the prediction of the disease phenotype in the human dataset
(with an average SSE under 0.18), and similar values were
obtained for the Drosophila and mouse datasets. The interspecies
disease networks have very high predictive value for other species
while they tend to avoid overfitting to a given dataset. This is
evident from the low level of variation in SSE between constructed
interspecies networks (0.06 in human, 0.11 in mouse, and 0.08 in
Drosophila). The predictive ability of the interspecies models is
highly robust towards the use of different organisms for training
and testing, as the average SSE for a given species only slightly
varies between different networks. Furthermore, the generated
interspecies disease networks exhibit high sensitivity and specificity
scores towards their informativeness to the prediction of the
disease status. The majority of these networks provide sensitivity
and specificity scores higher than 70% (Figure 4B). All
constructed networks perform significantly better than random
expectations, as presented in the ROC spaces (Figure 4B). In
addition, the gene networks are strongly connected to the class
node (representing information on the control and disease states of
the samples) since the number of genes connected to the class node
only drops to 0 when the confidence threshold was raised to 0.3,
0.4, or 0.2 for networks learnt on human, mouse, or Drosophila,
respectively (Figure 4C). These are very restrained confidence
thresholds as they require networks to share the same level of
Figure 3. Performance of the naı¨ve Dandelion algorithm on constructing disease networks that are learnt on human and evaluated
on human, mouse and Drosophila datasets. A) The average Sum of Squared Error (SSE) for prediction of the disease phenotype (OPMD vs.
control) given the gene expression profiles within the disease networks learnt on human. The cross-validation set which is used during the training
phase is depicted by C.V. and the independent test sets are grouped as IND. Test Sets. B) ROC space demonstrates the relative sensitivity and
specificity of the generated networks in predicting the disease phenotype. The results from random expectations are illustrated by the red dash-line.
C) Number of relationships between genes and the class node, after applying confidence thresholds, are depicted in line per species. D) The number
of links found after interspecies translation and optimization of the disease networks within each species. The orange section, separated by red dash-
line, represents the number of links that can be found in all species with the confidence threshold of 0.1. E) The interspecies disease domain is
generated according to the Markov blanket criteria, after applying the confidence threshold of 0.1.
doi:10.1371/journal.pcbi.1002258.g003
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confidence for interactions across all species, and compare
favorably to the low number of links remaining at the lower
threshold of 0.1 with the naı¨ve Dandelion algorithm.
Figure 5 demonstrates the level of robustness and translatability
of the obtained disease networks. A large fraction of relationships
(37.4% in human, 28.7% in mouse, and 34.3% in Drosophila) can
be translated and found in the interspecies disease network with
the confidence threshold of 0.1 (Figure 5A). Remarkably, an
average of more than 60% of the translated links can be found in
all organisms. It is evident that the intraspecies networks are highly
resistant towards noise and the range of confidence in which
interactions can be found in the training set is at least 0.7 and are
as high as 0.9 in Drosophila and mouse datasets (Figure 5B). This
value is even higher for relationships that are successfully
translated from the intraspecies network to the other organisms
(Figure 5B). Noticeably, the interspecies networks can still be
obtained when applying a very stringent confidence threshold of
0.9 for all three constructed interspecies disease networks. More
than 71% and 39% of translated relationships from human pass
the confidence threshold of 0.9 in mouse and Drosophila datasets,
respectively. However, a slightly more severe drop in translatabil-
ity rate is observed for networks learnt on the mouse data. This
can be expected due to the presence of overexpression and
possibly other artifacts in this model system, also reflected by the
higher level of interconnectivity of these networks. Despite the
presence of noise and other artifacts in these datasets, a large
fraction of interactions between genes encoding for the protea-
some have high confidence scores in the interspecies networks
(Figure 5B). This is not true for links associated with the
randomly selected genes as the majority of those relationships do
not pass the confidence threshold of 0.1 (Figure 5C). Overall,
these results show model-driven selective and predictive ability of
the exhaustive Dandelion algorithm in capturing the disease-
related relationships between genes in which exhaustive Dandelion
significantly outperforms the naı¨ve Dandelion algorithm.
To assess the specificity of the proteasome in providing accurate
prediction of the disease status, we compared the SSE, sensitivity,
and specificity of the networks learnt on the proteasome to that of
three additional gene sets. The exhaustive Dandelion algorithm
was applied to a set of 70 random genes from which none is
Figure 4. Performance of the exhaustive Dandelion algorithm. A) The average Sum of Squared Error (SSE) for prediction of the disease
phenotype (OPMD vs. control) given the gene expression profiles within the disease networks learnt on human (i), mouse (ii), or Drosophila (iii). The
cross-validation set which is used during the training phase is depicted by C.V. and the independent test sets are grouped as IND. Test Sets. B) ROC
space demonstrates the relative sensitivity and specificity of the generated networks in predicting the disease phenotype. The results from random
expectations are illustrated by the red dash-line. C) Number of relationships between genes and the class node, after applying confidence thresholds,
are depicted in line per species.
doi:10.1371/journal.pcbi.1002258.g004
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deregulated (ND) in OPMD, a set of 100 randomly selected genes
containing also deregulated genes that are expected to link with
the class node in one species but not necessarily across species, and
87 genes coding for the structurally-related ribosomal proteins,
which are not known to be consistently differentially expressed in
different species [19]. Noticeably, interspecies networks construct-
ed on the proteasome significantly outperformed (86% sensitivity
and 81% specificity across species) those constructed on other gene
sets (Figure 6). Strikingly, the predictive accuracy of networks
learnt on the proteasome was slightly improved from the previous
experiment (Figure 4) in which additional 30 random genes were
included. In contrast, the class prediction performance of the other
networks was much lower. The class prediction error for networks
learnt on the random genes was much higher than that of the
proteasomal genes (average SSE of 0.43 and 0.21, respectively) but
slightly lower than that of non-deregulated random genes and the
ribosome (0.52, and 0.48, respectively) (Figure 6A). Although the
performance is still acceptable for training and testing on human,
the decrease in the level of sensitivity and specificity of non-
proteasomal networks is particularly apparent during the transla-
Figure 5. Translatability and robustness of interspecies disease networks. A) The number of links that were found during interspecies
translation and optimization of the disease networks per individual datasets. The red dash-line depicts the number and fraction of links that can be
found in all species with the confidence threshold of 0.1. The translatability of disease networks learnt and trained on human (i), mouse (ii), and
Drosophila (iii) are presented separately. The cross-validation set which is used during the training phase is depicted by C.V. and the independent test
sets are grouped as IND. Test Sets. B) The translatability of relationships over series of different confidence thresholds. These line plots demonstrate
the percentage of relationships with confidence score higher than the threshold. For the independent testing datasets the ratio is towards the
number of links that were expected to be found after generation of the network map. C) The robustness of disease networks are assessed according
to the level of connectivity for genes encoding for the proteasome as compared to the set of randomly selected genes at different confidence
thresholds.
doi:10.1371/journal.pcbi.1002258.g005
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tion phase (in this case from human data to mouse and Drosophila)
(Figure 6B), indicating that the links between non-proteasomal
genes are not conserved across the different species. Altogether,
these results indicate a model-driven selective ability of the
algorithm in capturing the most informative and consistent gene
relationships which led to the construction of a highly robust
interspecies disease network.
Network Genes and Identification of Key Regulators
Interspecies disease domains represent the most robust, disease-
associated gene networks. They are identified by the class node
(describing the disease status) and the associated Markov blanket
of interactions with the confidence threshold of 0.1 across species
(Figure 7). In the original experiment, the interspecies disease
domain that is trained on human data shows the most robust
network as the overall confidence in relationships is very high
(Figure 7A). The mouse data, however, produced the highest
number of relatively weaker relationships among genes
(Figure 7B). The interspecies disease domain that is trained on
the Drosophila data shows the same level of robustness as those
constructed and trained on human (Figure 7C). In Drosophila,
Desmin (DES), a randomly selected gene, is connected to the class
node as part of the disease domain. Although DES (a muscle-
specific class III intermediate filament) is a member of the random
set, it is significantly deregulated in both human and Drosophila
datasets. This gene has been clearly linked to muscle differenti-
ation [30] and is likely associated with the OPMD phenotype. No
other randomly selected genes appear in the disease network
which indicates the reliability and the specificity of the obtained
networks. Overall, the interspecies disease domains exhibit a high
Figure 6. Specificity of the proteasome towards prediction of disease states. A) The average Sum of Squared Error (SSE) for prediction of
the disease phenotype (OPMD vs. control) given the gene expression profiles within the constructed networks learnt on the proteasome, 100 random
genes, 70 not-deregulated random genes (ND), and the ribosome. The cross-validation set which is used during the training phase is depicted by C.V.
and the independent test sets are grouped as IND. Test Sets. B) ROC space demonstrates the relative sensitivity and specificity of the generated
networks in predicting the disease phenotype. The proteasome, 100 random genes, 70 random genes (ND), and ribosome are illustrated in different
colors (red, purple, green, and yellow, respectively). The results from random expectations are illustrated by the gray dash-line.
doi:10.1371/journal.pcbi.1002258.g006
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level of robustness and informativeness towards different states of
the disease. This is due to the presence of relationships that can be
translated across species with at least a moderate confidence
(91.7% in human, 55.3% in mouse, and 71.4% in Drosophila).
Moreover, the interspecies disease domains contain a large
number of nodes that are differentially expressed in at least one
species (100% in human, 80% in mouse, and 92.9% in Drosophila).
Furthermore, the majority of genes are shared between at least two
interspecies disease domains (81.8%, 64%, and 78.6%, for disease
domains after training on human, mouse and Drosophila,
respectively). Many of the links between genes present in these
network structures demonstrate a strong correlation in expression
profiles in the different species (Table S4 in Text S1). Overall,
these results indicate that the expression levels of the majority of
genes in the constructed interspecies networks are strongly
correlated and more likely to be associated with the OPMD
phenotype than genes that are differentially expressed in single
species.
Evaluation of Disease Networks on Unseen Disease
Model
The model-driven and interspecies selection of genes that are
most likely to be associated with the disease phenotype suggests
their association with the disease in an independent and unseen
disease model. Therefore, we evaluated the disease-related
transcriptional changes for a subset of genes (selected from the
interspecies disease domains) in the IM2 cell model [29] with
moderate overexpression of the wild-type PABPN1 (WTA) or the
mutant PABPN1 protein isoform (D7E). Remarkably, all the
selected genes (PA28a, RPT3, RPN15, RPN11, b2, and b5) showed
significant differential expression in an unseen IM2 cell model
(Figure 8). PA28a appears to be an essential hub in the
interspecies disease domains trained on the human and mouse
datasets (Figure 7). Noticeably, it is also significantly deregulated
between D7E and WTA (Figure 8). In contrast, PA28b, which is
a closely related homolog in the PA28 complex [31] and also
significantly deregulated in human dataset, do not play a part in
the interspecies disease domains. Interestingly, it is evident that the
expression pattern of PA28b is not deregulated between the D7E
and WTA cells (Figure 8). Next, we assessed the expression of the
b2i, a member of immunoproteasome core subunit, present in the
interspecies disease domain constructed with the naı¨ve Dandelion
algorithm. This gene is not differentially expressed between D7E
and WTA cells (Figure 8). Overall, these results highlight the
unique ability of the exhaustive Dandelion algorithm to identify
disease-related genes that can be found across different OPMD
model systems and patients.
Discussion
Integration of transcriptome data from different species is far
from trivial and is complicated by our limited knowledge of true
Figure 7. Interspecies disease domains. These interspecies class network structures are learnt on human (A), mouse (B), or Drosophila (C)
dataset and optimized across species. Class network structures are presented according to Markov blanket criteria. Nodes represent genes. The outer
ring reflects deregulation in the expression in the different species (a, b). Relationships are depicted with lines that represent different degree of
confidence in relationships (described in c).
doi:10.1371/journal.pcbi.1002258.g007
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protein orthologues and transcript variants coding for proteins
with similar functions. Moreover, the presence of noise and
artifacts specific to certain model systems usually leads to limited
overlap between results obtained in cross-species comparisons [32–
35]. In this paper, we developed a Bayesian-based methodology
(Dandelion algorithm) to model gene networks associated with the
same disease in different species. We showed that the integration
and analysis of gene expression datasets from various species
increase the robustness of the constructed networks and the
predictive accuracy of the disease state. We also demonstrated that
the interspecies translation of the networks helps to avoid
overfitting. A newly developed model-driven selection of tran-
scripts that are most likely to be coding for orthologous proteins is
essential for the generation of robust interspecies disease networks.
Our approach for Bayesian modeling of datasets on a similar
phenotype from different model systems and patients is rather
unique. Several approaches have been described to avoid over-
fitting and increase the robustness of Bayesian networks. For
example, informative priors derived from protein-protein interac-
tion (PPI) data or from the literature have been used to generate
more stable and biologically meaningful networks [13–15,36].
While these methods obviously bias the results towards well-known
regulatory interactions [37,38], these methods may ultimately be
combined with our modeling approach to obtain regulatory
networks with a more straightforward biological interpretation.
Our method was applied to an a priori defined gene module
coding for a well-known biological structure, the proteasome.
Several studies in S. cerevisiae [39–42] have demonstrated the value
of an integrative modeling approach providing modularized
interaction networks without prior assumptions. Zhang et al.
[39], for instance, took an approach in which they integrated a
number of different available data sources, from PPIs to sequence
homology and gene co-expression, while Tanay et al. [40] and
others [41,42] expanded on the statistical analysis of network
properties and identifying modules within the network structure.
The performance of these models depends on the availability of
high quantities of samples and may be prone to overfitting due to
the presence of noise and other model-specific artifacts. Therefore,
a combination with our interspecies translation approach may
enable the allowing of larger gene regulatory networks with
multiple gene modules and connections between them.
In this study, three microarray datasets from Drosophila, mouse
and human, that are all concerned with OPMD, are used to gain
insight into key regulatory relationships of interspecies disease
networks that are directly and robustly associated with the disease.
Previously, we have established the importance of the deregulation
of the ubiquitin-proteasome system (UPS) for the disease etiology
[19]. From the different components of the UPS, the down-
regulation of the proteasome has been associated with the late-
onset of the disease [19] as the reduced proteasome activity can
Figure 8. Validation of differential expression of disease associated genes in an unseen disease model. Results from qPCR experiments
measuring differences in gene expression between control cells (WTA, N = 3 independent cultures) and cells expressing the OPMD-associated
PABPN1 with expanded repeat (D7E, N = 3 independent cultures). Expression levels were normalized to Desmin to correct for differences in the
myogenicity in the different cell cultures. Significant differences (P,0.05, Student’s T-test) between measured expression values in D7E and WTA cells
are indicated by *, whilst NS stands for no significant difference. PA28a, RPT3, RPN15, RPN11, b2, and b5 expression in IM2 cell lines were selected from
the group of genes present in the interspecies disease domain. PA28b (deregulated in human dataset) was selected as its role in assembling the lid
subunit of the immunoproteasome is highly similar to PA28a but not part of the interspecies disease domain. b2i is one of the two genes that
remained connected to the class node in the interspecies disease domain constructed by naı¨ve Dandelion approach. ACTA1 is a control for myotube
formation.
doi:10.1371/journal.pcbi.1002258.g008
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lead to futile protein degradation. However, little is known about
the key components of the proteasome that are contributing to the
OPMD phenotype. Hence, the generation of interspecies disease
networks for the proteasome encoding genes now shed some light
on the underlying regulatory mechanisms that govern the disease-
related transcriptional changes of the proteasome encoding genes.
We identified PA28a, one of the three components of the PA28
subunit, as an important hub gene in the interspecies disease
domain and validated its significant differential expression in an
unseen disease model. PA28a plays an important role in
assembling the lid subunit of the immunoproteasome and
stimulating the proteasome core component [31]. Previously we
showed that the induction of immunoproteasome activity leads to
a significant reduction in the nuclear expPABPN1 accumulation
[19]. This observation further signifies the role of PA28 assembly
and the immunoproteasome in the disease etiology. In contrast,
the other PA28 component PA28b although significantly dereg-
ulated in human OPMD patients, appears to play a less crucial
role since its association with the disease did not translate to the
OPMD animal models and could not be reproduced in the
OPMD cell model system. On the other hand, the association of
b2 and b5, members of the proteasome core subunit, with the
disease was identified by the interspecies disease domains and
reproduced in the OPMD cell model. Down-regulation of the
proteasome core subunit can lead to futile protein degradation
which results in protein accumulation. Our analysis suggests that
b2 and b5 are vital regulators of the proteasome activity which are
disease associated. It has been shown that the down-regulation of
the proteasome core subunit can trigger expPABPN1 accumula-
tion and play a role in the disease late-onset [19]. Relevant to the
late-onset of the OPMD, previously it has been shown that the
proteasome activity declines during muscle ageing [43–45], a
phenomena which is highly associated with the transcriptional
changes of the proteasomal genes [45]. In follow-up studies, the
functional role of proteasomal protein dysregulation in the disease
pathology and ageing of muscles needs to be investigated.
Furthermore, the functional relevance of gene regulatory relation-
ships should be investigated where changes in protein level mimic
the in vivo situation and directly affect the protein catabolism. This
would ultimately result in better understanding of the mechanism
in which the loss of proteostasis leads to degenerative loss of muscle
function during ageing and in OPMD.
In conclusion, this study presents a state-of-the-art strategy in
constructing interspecies disease networks that provide crucial and
comprehensive information on gene regulatory relationships. This
leads to better understanding and identification of the molecular
mechanisms underlying the disease. The high level of specificity
and sensitivity of these models enables the prioritization of
candidate regulators of molecular disease mechanisms to be
studied in follow-up validation experiments. In particular, it is
crucial to carry out additional experiments to investigate the
functional relevance of proteasomal proteins dysregulation to the
OPMD pathology. We believe that robust and unbiased
construction of the interspecies networks for rare or complex
human diseases can lead to novel discovery and identification of
key regulators which can ultimately offer potential targets for
therapeutic interventions and drug developments.
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